Short peptide analogs as alternatives to collagen in pro-regenerative corneal implants

Short collagen-like peptides (CLPs) are being proposed as alternatives to full-length collagen for use in tissue engineering, on their own as soft hydrogels, or conjugated to synthetic polymer for mechanical strength. However, despite intended clinical use, little is known about their safety and effi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jangamreddy, Jaganmohan R, Haagdorens, Michel K.C, Islam, M. Mirazul, Lewis, Philip, Samanta, Ayan, Fagerholm, Per, Liszka, Aneta, Ljunggren, Monika K, Buznyk, Oleksiy, Alarcon, Emilio I, Zakaria, Nadia, Meek, Keith M, Griffith, May
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Short collagen-like peptides (CLPs) are being proposed as alternatives to full-length collagen for use in tissue engineering, on their own as soft hydrogels, or conjugated to synthetic polymer for mechanical strength. However, despite intended clinical use, little is known about their safety and efficacy, mechanism of action or degree of similarity to the full-length counterparts they mimic. Here, we show the functional equivalence of a CLP conjugated to polyethylene glycol (CLP-PEG) to full-length recombinant human collagen in vitro and in promoting stable regeneration of corneal tissue and nerves in a preclinical mini-pig model. We also show that these peptide analogs exerted their pro-regeneration effects through stimulating extracellular vesicle production by host cells. Our results support future use of CLP-PEG implants for corneal regeneration, suggesting the feasibility of these or similar peptide analogs in clinical application in the eye and other tissues. Correction in: Acta Biomaterialia, Vol. 81, Pages 330-331.DOI: 10.1016/j.actbio.2018.10.009Correction in: Acta Biomaterialia, Vol.88, Pages 556-557.DOI: 10.1016/j.actbio.2019.01.046
DOI:10.1016/j.actbio.2018.01.011